Compare Bio Protocol (BIO) vs Venom (VENOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Venom — how do they compare? Bio Protocol trades at Rp516.76 (market cap Rp1,15T, Rp264,79M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Bio Protocol is far larger — about 3373.8× Venom's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 988,9M / 8B VENOM (13%) for Venom. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Venom for 21 Days on average.
| BIO | VENOM | |
|---|---|---|
Market Cap | Rp1,15T | Rp340,86M |
Volume (24h) | Rp264,79M | Rp2,89M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 16 Days | 21 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Venom (VENOM) is a low-circulation cryptocurrency with a market cap of Rp340.86 million and only 13% of its 8 million max supply in circulation. Current price data is unavailable, but the asset shows limited trading activity with a hold time of 21 days, indicating low liquidity and minimal recent market movement. No major protocol updates or ecosystem developments are reported, suggesting stagnant network growth.
Overall outlook is cautious due to low liquidity and limited adoption. Key opportunities include potential price appreciation if circulation increases, but major risks involve high volatility from thin order books and regulatory uncertainty in the crypto space. Investors should monitor exchange listings and on-chain activity for signs of revival.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Venom
Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →
